Indian Drugs and Pharmaceuticals Limited (IDPL) is a public sector pharmaceutical, bulk drug manufacturing and drug discovery company owned by the Indian government, headquartered in New Delhi, and located in Hyderabad, Gurgaon and Rishikesh.:[1] The company is involved in patent development alongside, National Institute of Pharmaceutical Education and Research to provide affordable drugs, and has recently released three over the counter drugs.[2][3]
| Company type | Public sector undertaking |
|---|---|
| Founded | 1961 |
| Headquarters | New Delhi Hyderabad Gurgaon Rishikesh |
| Products | Drugs and pharmaceuticals |
| Website | Official website |
A new formulation unit was inaugurated in Hyderabad in February 2017.
Many attempts have been made to revive IDPL, declared sick by the Board for Industrial and Financial Reconstruction. The Government of India is exploring ways of strategically selling the unit and meet outstanding liabilities. On the 9th of February 2021, the Government of India announced the liquidation of IDPL.[4]
See also
editReferences
edit- ^ http://pharmaceuticals.gov.in/cpsu.pdf [bare URL PDF]
- ^ "IDPL Introduces Three New OTC Drugs - Pharmaceuticals & Healthcare Insight". Archived from the original on 24 March 2012. Retrieved 30 May 2011.
- ^ "Department of Chemicals and Petrochemicals-Ministry of Chemicals and Fertilizers-Pharmaceuticals". Archived from the original on 11 June 2011. Retrieved 30 May 2011.
- ^ "Govt has decided to shut 2 pharma PSUs, disinvest other 3: Govt tells LS". Business Standard India. Press Trust of India. 9 February 2021.
  | This article about an Indian company is a stub. You can help Wikipedia by expanding it. |